The growth for the year will normalise around 20%: Venkat Jasti, Chairman & CEO, Suven Life Science
"Specialitychemicals has more or less reached the top. It has reached saturation level and the growth will be 3 per cent to 5 per cent over the year," said Jasti. Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Suven Life Sciences Ltd has informed BSE regarding the details of Voting results at the 27th Annual General Meeting (AGM) of the Company held on August 10, 2016, under Regulation 44(3) of SEBI (LODR) Regulations, 2015 along with Scrutinizer's Report and Proceedings of the Meeting in this regard. Standalone Financial Results, Limited Review Report, Results Press Release for June 30, 2016
Suven Life Sciences Ltd has informed BSE about : 1. Standalone Financial Results for the period ended June 30, 20162. Standalone Limited Review for the period ended June 30, 20163. Result Press Release for the period ended June 30, 2016 Schedule of Conference Call for Investors
Suven Life Sciences Ltd has informed BSE regarding "Schedule of Conference Call for Investors". Board Meeting Intimation for Results & Closure of Trading Window
Suven Life Sciences Ltd has informed BSE that a Board Meeting of Board of Directors of the Company will be held on August 10, 2016, inter alia, to consider and take on record the following matter(s): To consider and approve the Un-audited Financial Results of the Company for the first quarter ended June 30, 2016.Further, TRADING WINDOW for dealing in the securities of the company was closed from August 02, 2016 to August 12, 2016... Suven Life Sciences bags 2 patents
Suven Life Sciences Ltd has secured two patents, one each from Macau and New Zealand, corresponding to its New Chemical Entities (NCEs) for the treatment of disorders associated with neurodegenerativ... Suven Life Sciences secures two (2) Product Patents in Macau and New Zealand
Suven Life Sciences Ltd has informed BSE regarding a Press Release dated August 01, 2016, titled "Suven Life Sciences secures two (2) Product Patents in Macau and New Zealand". Suven to Present at Alzheimer's Association International Conference (AAIC)
Suven Life Sciences Ltd has submitted to BSE a copy of Press Release dated July 25, 2016 titled ''Suven to Present at Alzheimer's Association International Conference (AAIC)".